Publications by authors named "Loreen Walker"

Claim this Profile
U
Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of Medicare beneficiaries from 2007 to 2008.
Jacqueline B Palmer, Jennifer S Albrecht, Yujin Park, Sarah Dutcher, Gail B Rattinger, Loreen D Walker

Drugs Aging· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of medications on physical function and cognition in nursing home residents with dementia.
Sarah K Dutcher, Gail B Rattinger, Patricia Langenberg, Pankdeep T Chhabra, Xinggang Liu, Loreen D Walker

J Am Geriatr Soc· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consideration of ICD-9 code-derived disease-specific safety indicators in CKD.
Iris R Hartley, Jennifer S Ginsberg, Clarissa J Diamantidis, Min Zhan, Loreen Walker

Clin J Am Soc Nephrol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sustainable strategy to prevent misuse of antibiotics for acute respiratory infections.
Gail B Rattinger, C Daniel Mullins, Ilene H Zuckerman, Eberechukwu Onukwugha, Loreen D Walker

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacotherapeutic management of dementia across settings of care.
Gail B Rattinger, Mehmet Burcu, Sarah K Dutcher, Pankdeep T Chhabra, Paul B Rosenberg, Loreen D Walker

J Am Geriatr Soc· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.
Krupa Patel, Clarissa Diamantidis, Min Zhan, Van Doren Hsu, Loreen D Walker

Am J Nephrol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A varying patient safety profile between black and nonblack adults with decreased estimated GFR.
Clarissa J Diamantidis, Stephen L Seliger, Min Zhan, Loreen Walker, Gail B Rattinger

Am J Kidney Dis· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease.
Stephen L Seliger, Amy D Zhang, Matthew R Weir, Loreen Walker, Van Doren Hsu

Kidney Int· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.
Stephen Seliger, Kathleen M Fox, Shravanthi R Gandra, Brian Bradbury, Van Doren Hsu, Loreen Walker

Clin J Am Soc Nephrol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse safety events in chronic kidney disease: the frequency of "multiple hits".
Erica Chapin, Min Zhan, Van Doren Hsu, Stephen L Seliger, Loreen D Walker

Clin J Am Soc Nephrol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CKD as an underrecognized threat to patient safety.
Jeffrey C Fink, Jeanine Brown, Van Doren Hsu, Stephen L Seliger, Loreen Walker

Am J Kidney Dis· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis